Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edith Borcoman

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 28, 2023
Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancersEdith Borcoman, Ana Lalanne, Jean-Pierre Delord, et al.
Nature Medicine|October 19, 2023
BrainStorm: a multicenter international study to tackle CNS metastases in solid tumorsDiogo Martins-Branco, Guilherme Nader-Marta, Andrea Gombos, et al.
Molecular Oncology|August 5, 2020
Fine-needle aspiration as an alternative to core needle biopsy for tumour molecular profiling in precision oncology: prospective comparative study of next-generation sequencing in cancer patients included in the SHIVA02 trialCélia Dupain, Julien Masliah-Planchon, Céline Gu, et al.
Nature Communications|May 3, 2024
CD74 supports accumulation and function of regulatory T cells in tumorsElisa Bonnin, Maria Rodrigo Riestra, Federico Marziali, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2021
A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trialRachel Galot, Christophe Le Tourneau, Esma Saada-Bouzid, et al.
Scientific Reports|December 19, 2023
Randomized phase II study of preoperative afatinib in untreated head and neck cancers: predictive and pharmacodynamic biomarkers of activityGrégoire Marret, Stéphane Temam, Maud Kamal, et al.
Nature Communications|October 31, 2024
Author Correction: The genomic and transcriptomic landscape of metastastic urothelial cancerYohann Loriot, Maud Kamal, Laurene Syx, et al.
Nature Communications|October 4, 2024
The genomic and transcriptomic landscape of metastastic urothelial cancerYohann Loriot, Maud Kamal, Laurene Syx, et al.
BMC Biology|February 20, 2024
Tumor mutational burden assessment and standardized bioinformatics approach using custom NGS panels in clinical routineCélia Dupain, Tom Gutman, Elodie Girard, et al.
Molecular Oncology|April 10, 2022
Human papilloma virus integration sites and genomic signatures in head and neck squamous cell carcinomaJuliette Mainguené, Sophie Vacher, Maud Kamal, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|July 28, 2023
Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancersEdith Borcoman, Ana Lalanne, Jean-Pierre Delord, et al.
Nature Medicine|October 19, 2023
BrainStorm: a multicenter international study to tackle CNS metastases in solid tumorsDiogo Martins-Branco, Guilherme Nader-Marta, Andrea Gombos, et al.
Molecular Oncology|August 5, 2020
Fine-needle aspiration as an alternative to core needle biopsy for tumour molecular profiling in precision oncology: prospective comparative study of next-generation sequencing in cancer patients included in the SHIVA02 trialCélia Dupain, Julien Masliah-Planchon, Céline Gu, et al.
Nature Communications|May 3, 2024
CD74 supports accumulation and function of regulatory T cells in tumorsElisa Bonnin, Maria Rodrigo Riestra, Federico Marziali, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2021
A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trialRachel Galot, Christophe Le Tourneau, Esma Saada-Bouzid, et al.
Scientific Reports|December 19, 2023
Randomized phase II study of preoperative afatinib in untreated head and neck cancers: predictive and pharmacodynamic biomarkers of activityGrégoire Marret, Stéphane Temam, Maud Kamal, et al.
Nature Communications|October 31, 2024
Author Correction: The genomic and transcriptomic landscape of metastastic urothelial cancerYohann Loriot, Maud Kamal, Laurene Syx, et al.
Nature Communications|October 4, 2024
The genomic and transcriptomic landscape of metastastic urothelial cancerYohann Loriot, Maud Kamal, Laurene Syx, et al.
BMC Biology|February 20, 2024
Tumor mutational burden assessment and standardized bioinformatics approach using custom NGS panels in clinical routineCélia Dupain, Tom Gutman, Elodie Girard, et al.
Molecular Oncology|April 10, 2022
Human papilloma virus integration sites and genomic signatures in head and neck squamous cell carcinomaJuliette Mainguené, Sophie Vacher, Maud Kamal, et al.
Pageof 6